Chlamydia Infection Diagnostics Market Outlook:
Chlamydia Infection Diagnostics Market size was over USD 1.57 billion in 2025 and is projected to reach USD 3.21 billion by 2035, growing at around 7.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of chlamydia infection diagnostics is evaluated at USD 1.67 billion.
Chlamydia is asymptomatic and many young individuals are unaware of STDs and associated risks. This lack of awareness contributes to its higher transmission rates, fuelling the need for advanced chlamydia infection diagnostic solutions. As the prevalence rate increases, the need for effective diagnostic solutions to identify and treat infections promptly booms. This demand drives innovation and investment in chlamydia testing technologies.
For instance, according to the World Health Organization (WHO), around 128.5 million new chlamydia infection cases were registered among the age group of 15 to 49 across the world, in 2022. Particularly for this demographic, the prevalence rate among women was 4.0% and 2.5% in men. Untreated chlamydia can cause serious issues such as HIV or other STIs. To minimize the prevalence rate of chlamydia, public and private healthcare organizations are implementing targeted screening programs and educational campaigns, further boosting the sales of diagnostic solutions.
